{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T09:24:03Z","timestamp":1746696243666,"version":"3.37.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":4322,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[1997,3]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>8\u2010ornithine\u2010vasopressin (ornipressin, POR\u20108\u00ae) is used as a potent peripheral vasoconstrictor mainly in combination with local anaesthetics. Because omipressin causes vasoconstriction, any myocardial depressive effects could be caused indirectly by reduced myocardial perfusion secondary to coronary vasoconstriction, or directly by effects on myocardial tissue.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>On isolated guinea pig hearts, we compared direct effects of ornipressin by perfusion at constant flow with indirect effects by perfusion at constant pressure by Langendorff technique. Ornipressin concentrations tested were 0.05, 0.1, 0.25, 0.5 and 1.0 IU\/L (1 International Unit (IU) omipres\u2010sin=2.8 \u03bcg)<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Coronary flow decreased significantly (P&lt;0.001) in concentration\u2010dependent manner with ornipressin at constant pressure while AV conduction time and percentage O<jats:sub>2<\/jats:sub>extraction (%O<jats:sub>2<\/jats:sub>E) increased and heart rate (HR), systolic left ventricular pressure (LVP) and myocardial O<jats:sub>2<\/jats:sub>consumption (MVO<jats:sub>2<\/jats:sub>) decreased. Coronary perfusion pressure increased significantly with increasing omipressin at constant coronary flow while HR and AV time were unchanged and LVP decreased only at the higher concentrations. At an identical or slightly reduced HR\u2010LVP product (RPP), MVO<jats:sub>2<\/jats:sub>increased up to 27\u00b16% at 1.0 IU\/L omipressin during constant flow perfusion.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>An increase in %O<jats:sub>2<\/jats:sub>E coupled with a decrease in coronary flow at constant pressure is consistent with myocardial depression secondary to reduced tissue perfusion. These omipressin\u2010induced effects are not evident at constant coronary flow except for a small but direct myocardial depressant effect on LVP at higher concentrations. The increase of MVO<jats:sub>2<\/jats:sub>at constant flow, despite equal or even reduced work, is described as Gregg's phenomenon and it is probably due to an increase in coronary perfusion pressure during coronary vasoconstriction. Even though extrapolation of our results in humans is questionable, the current indication for use of ornipressin as vasoconstrictor may need to be reconsidered, especially in patients with reduced coronary reserve.<\/jats:p>","DOI":"10.1111\/j.1399-6576.1997.tb04708.x","type":"journal-article","created":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T04:24:38Z","timestamp":1230783878000},"page":"414-421","source":"Crossref","is-referenced-by-count":7,"title":["Synthetic 8\u2010ornithine\u2010vasopressin, a clinically used vasoconstrictor, causes cardiac effects mainly via changes in coronary flow"],"prefix":"10.1111","volume":"41","author":[{"given":"B. M.","family":"GRAF","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"FISCHER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. F.","family":"STOWE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. J.","family":"BOSNJAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. O.","family":"MARTIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"187","article-title":"Vasoconstrictors and experimental flaps","volume":"131","author":"Klingenstr\u00f6m P","year":"1966","journal-title":"Acta Chir Scand"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1967.tb00366.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-198405000-00013"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1964.tb00247.x"},{"issue":"2","key":"e_1_2_1_6_2","article-title":"The influence of local anaesthetics on living tissues in white rat","author":"Bj\u00f6rlin G.","year":"1954","journal-title":"Odont Ra"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-196509000-00006"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-196811000-00003"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(62)90243-X"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1951.63670120002009a"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01907696"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1971.tb92555.x"},{"key":"e_1_2_1_13_2","first-page":"181","article-title":"On surgical hemorrhages in relation to local anesthesia. I. Comparative clinical studies on the va\u2010soconstricting action of epinephrine, norepinephrine and octapressin. [German]","volume":"14","author":"Rintala A","year":"1965","journal-title":"Anaesthesist"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0007-1226(70)80014-5"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/45.5.511"},{"key":"e_1_2_1_16_2","first-page":"144","article-title":"Comparison of the haemostatic and cardiovascular effects of adrenaline and omithine\u20108\u2010va\u2010sopressin (POR 8) in middle ear operations","volume":"26","author":"Saamivaara L","year":"1977","journal-title":"Anaesthesist"},{"key":"e_1_2_1_17_2","first-page":"434","article-title":"A fatal hypertensive reaction during anesthesia in a patient with acute subarachnoid hemorrhage. [German]","volume":"39","author":"Graf BM","year":"1990","journal-title":"Anaesthesist"},{"key":"e_1_2_1_18_2","first-page":"653","article-title":"Supraventricular tachycardia following POR 8 (Ornipressin)\u2010administration in an infant. [German]","volume":"36","author":"Abel M","year":"1987","journal-title":"Anaesthesist"},{"key":"e_1_2_1_19_2","first-page":"320","article-title":"Signs of a severe myocardial ischemia following peritonsillar infiltration with ornipressin (POR 8). [German]","volume":"42","author":"Veit S","year":"1993","journal-title":"Anaesthesist"},{"key":"e_1_2_1_20_2","first-page":"150","article-title":"Unenv\u00fcnschte kardio\u2010vaskul\u00e4re und systemische Wirkungen von Ornipressin (POR\u20108\u00ae) und deren Therapie mit Dipyridamol (Persantin\u00ae). Eine tierexperimentelle Studie","volume":"37","author":"Poetcko C","year":"1992","journal-title":"Anaesthesist"},{"key":"e_1_2_1_21_2","first-page":"597","article-title":"Ornipressin (POR 8) \u2010 effect on coronary blood circulation and the peripheral circulation. An animal experimental study. [German]","volume":"42","author":"Veit S","year":"1993","journal-title":"Anaesthesist"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199106000-00017"},{"key":"e_1_2_1_23_2","first-page":"149","article-title":"POR 8 (omipressin). Local vasoconstrictive effect and hemodynamic activity during surgery in ENT clinics. [German]","volume":"33","author":"Hirlinger WK","year":"1984","journal-title":"Anaesthesist"},{"key":"e_1_2_1_24_2","first-page":"80","article-title":"Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle","volume":"43","author":"Altura BM","year":"1984","journal-title":"Federation Proceedings"},{"key":"e_1_2_1_25_2","first-page":"H734","article-title":"Direct cardiac effects of vasopressin and their reversal by a vascular antagonist","volume":"251","author":"Boyle WA","year":"1986","journal-title":"Am J Physiol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-3565(25)27674-1","article-title":"Studies on the cardiovascular effects of synthetic Vasopressin","volume":"157","author":"Nakano J.","year":"1967","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.37.363"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198004000-00017"},{"key":"e_1_2_1_29_2","first-page":"H261","article-title":"Direct cardiac effects of vasopressin: role of V1\u2013 and V2\u2010vasopressinergic receptors","volume":"255","author":"Walker BR","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.76.4.592"},{"key":"e_1_2_1_31_2","first-page":"163","volume-title":"Circulation. Proceedings of the Harvey Tercentenary Congress","author":"Gregg DE.","year":"1958"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00602910"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.47.4.599"},{"key":"e_1_2_1_34_2","first-page":"H2359","article-title":"Coronary pressure\u2010flow autoregulation protects myocardium from pressure\u2010induced changes in oxygen consumption","volume":"266","author":"Bai XJ","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_1_35_2","first-page":"A612","article-title":"Vaso\u2010pressin and myocardial oxygen demand \u2010 a model 1 for the Gregg's phenomenon","volume":"83","author":"Graf BM","year":"1995","journal-title":"Anesthesiology"},{"key":"e_1_2_1_36_2","first-page":"S87","article-title":"Pressure related changes in regional myocardial contractility and internal resistance: mechanism of Gregg phenomenon (Abstract)","volume":"25","author":"Iwamoto T","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90808-5"},{"key":"e_1_2_1_38_2","first-page":"17","article-title":"The cardiovascular effects of octapressin","volume":"158","author":"Maxwell GM.","year":"1965","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1978.sp012275"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.1997.tb04708.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.1997.tb04708.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:42:16Z","timestamp":1738863736000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.1997.tb04708.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1111\/j.1399-6576.1997.tb04708.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.1997.tb04708.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"type":"print","value":"0001-5172"},{"type":"electronic","value":"1399-6576"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}